Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 95 (Search time: 0.026 seconds).
Issue DateTitleAuthor(s)
2013Antiangiogehic Drugs for Colorectal Cancer: Exploring New PossibilitiesFERRAROTTO, Renata; HOFF, Paulo M.
2013Self-Reported Conflicts of Interest of Authors, Trial Sponsorship, and the Interpretation of Editorials and Related Phase III Trials in OncologyBARIANI, Giovanni M.; FERRARI, Anezka C. R. de Celis; HOFF, Paulo M.; KRZYZANOWSKA, Monika K.; RIECHELMANN, Rachel P.
2013Infection Related to Implantable Central Venous Access Devices in Cancer Patients: Epidemiology and Risk FactorsFREIRE, Maristela P.; PIERROTTI, Ligia C.; ZERATI, Antonio E.; ARAUJO, Pedro H. X. N.; MOTTA-LEAL-FILHO, J. M.; DUARTE, Laiane P. G.; IBRAHIM, Karim Y.; SOUZA, Antonia A. L.; DIZ, Maria P. E.; PEREIRA, Juliana; HOFF, Paulo M.; ABDALA, Edson
2012Squamous-cell carcinoma of the anal canal: Room for improvement with targeted therapyOLIVEIRA, Suilane; TEIXEIRA, Luis; HOFF, Paulo M.; GRAMONT, Aimery De; TOURNIGAND, Christophe
2013KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranibSMITH, John C.; BROOKS, Laura; HOFF, Paulo M.; MCWALTER, Gael; DEARDEN, Simon; MORGAN, Shethah R.; WILSON, David; ROBERTSON, Jane D.; JUERGENMEIER, Juliane M.
2013Outcomes of sunitinib therapy in patients (pts) with metastatic renal cell carcinoma (mRCC) with poor risk featuresBARROSO-SOUSA, Romualdo; MUNHOZ, Rodrigo Ramella; FONSECA, Leonardo Gomes; FEDE, Angelo Bezerra de Sousa; LINCK, Rudinei Diogo Marques; MONIZ, Camila Motta Venchiarutti; MAK, Milena Perez; SOUZA, Ciro Eduardo; HOFF, Paulo M.; DZIK, Carlos
2018Evaluation of F-18-FDG PET-CT as a prognostic marker in advanced biliary tract cancerBRAGHIROLI, Maria I.; MOTA, Jose M.; DUARTE, Paulo S.; MORITA, Tiago O.; BARIANI, Giovanni M.; NEBULONI, Daniela; BUCHPIGUEL, Carlos A.; HOFF, Paulo M.; RIECHELMANN, Rachel P.
2015Obesidade e câncerATTA, José Antonio; HOFF, Paulo M.
2013Should all patients (pts) with advanced biliary cancers receive first-line treatment with cisplatin and gemcitabine (GC)?MIRANDA, Vanessa Costa; DIB-FARIA, Luiza; BRAGHIROLI, Maria Ignez Freitas Melro; SABBAGA, Jorge; SARAGIOTTO, Daniel Fernandes; CASTRO, Gilberto; HOFF, Paulo M.; RIECHELMANN, Rachel
2013EGFR GENOTYPING AND EPIDEMIOLOGY, CLINICAL AND PATHOLOGICAL FEATURES IN 191 PATIENTS WITH METASTATIC PULMONARY ADENOCARCINOMA IN SAO PAULO - BRAZIL.CASTRO JR., Gilberto; TAKAHASHI, Tiago K.; CAIRES-LIMA, Rafael; PROTASIO, Bruno M.; MAIA, Manuel C. D. F.; SOARES, Ibere C.; ROITBERG, Felipe S. R.; MARINI, Andrea M.; MARTINS, Renata E.; TAKAGAKI, Teresa Y.; ARAUJO, Pedro H. X. N.; TERRA, Ricardo M.; SHIANG, Christina; SIQUEIRA, Sheila A. C.; MELLO, Evandro S.; ALVES, Venancio A.; HOFF, Paulo M.